Trump’s Anti-Malaria Drugs Proving to Be the Best Bet Against COVID-19

March 30, 2020 2:25 PM UTC
President Trump’s anti-malaria cocktail in hydroxychloroquine and azithromycin is showing promise in treating patients suffering from COVID-19.
  • President Trump’s anti-malaria cocktail of hydroxychloroquine and azithromycin is showing promise in treating patients suffering from COVID-19.
  • A renowned French physician conducted the study that confirmed the efficacy of the drugs against the deadly disease.
  • A New York doctor used the same treatment and also got amazing results.

President Donald Trump has taken flak after touting medications that can help cure COVID-19. In a tweet, the U.S. president said that the use of both hydroxychloroquine and azithromycin can be effective against the deadly disease.

Donald Trump on drugs that can help combat the novel coronavirus. | Source: Twitter

One of the most prominent critics of President Trump’s proposed drug mix is Dr. Anthony Fauci. The head of the National Institute of Allergy and Infectious Diseases said that the U.S. president based his comments on anecdotes as opposed to clinical studies.

Less than two weeks after Trump’s controversial tweets, clinical studies are showing that the combination of hydroxychloroquine and azithromycin is indeed effective against COVID-19.

Research Shows Efficacy of Drug Cocktail in Treating COVID-19

While Dr. Fauci was busy telling the media that COVID-19 deaths in the U.S. could top 100,000, French doctor Didier Raoult was curing patients with anti-malaria drugs. The renowned French physician led a study involving 80 COVID-19 patients.

The results of the study were astounding. Dr. Raoult’s team revealed that almost all of the 80 patients receiving a combination of hydroxychloroquine and azithromycin showed clinical improvement. The only exceptions were an 86 year-old patient who died and a 74 year-old patient who is still under intensive care.

By day eight of the treatment, 93% of the patients showed a negative viral load through a nasopharyngeal swab. The paper noted that the treatment,

allowed patients to rapidly be discharged from highly contagious wards with a mean length stay of five days.

At Méditerranée Infection University Hospital where Dr. Raoult conducted the study, over 503 patients are being treated with hydroxychloroquine and azithromycin. So far, only one patient has succumbed to COVID-19 while undergoing this treatment.

Southern France is winning the fight against COVID-19. | Source: Twitter

New York Physician Uses Same Treatment With 100% Efficacy

Dr. Vladimir Zelenko, a board-certified family physician in New York, treated 699 COVID-19 patients with zero deaths, zero intubations and four hospitalizations. Dr. Zelenko claims that the entire treatment costs $20 over a period of five days.

In an open letter to medical professionals across the globe, Dr. Zelenko wrote that hydroxychloroquine helps zinc penetrate the cell (zinc decelerates viral replication in the cell). He stated that azithromycin combats secondary infections.

Dr. Zelenko also noted that the outpatient treatment works without requiring most of his patients to be admitted to the hospital.

On Sunday, President Trump said that the anti-malaria drugs are being used to treat 1,100 patients in New York.

It appears that Trump’s statement about hydroxychloroquine and azithromycin is no longer based on anecdotes. Clinical studies show that the anti-malaria cocktail is indeed effective against COVID-19.

Disclaimer: this is not health advice. Consult your health physician if you experience COVID-19 symptoms.

Sam Bourgi edited this article for If you see a breach of our Code of Ethics or find a factual, spelling, or grammar error, please contact us.

Last modified: June 24, 2020 1:05 AM UTC

Show comments

Kiril is a CFA Charterholder and financial professional with 6+ years of experience in financial writing, analysis and product ownership. He has a bachelor's degree with a specialty in finance and lives in Canada. Kiril’s current focus is on finance and cryptocurrencies. He also has his personal website, Investor Academy, where he teaches people about the basics of investing. He owns Bitcoin, Ethereum, and other cryptocurrencies. He holds investment positions in the coins but does not engage in short-term or day-trading. Get in touch with Kiril: Muck Rack, Email, Follow on Twitter